Madrigal Pharmaceuticals, Inc. earnings per share and revenue

MDGL earnings per share for the last quarter are -2.71 USD whereas the estimation was -3.92 USD which accounts for 30.86% surprise. Company revenue for the same period amounts to 103.32 M USD despite the estimated figure of 99.09 M USD. Estimated earnings per share for the next quarter are -3.78 USD, and revenue is expected to reach 111.87 M USD. Also watch annual changes over time to get a bigger picture of MDGL earnings per share and revenue dynamics.